Healthcare -
Biotechnology - NASDAQ - US
$ 4.43
-1.56 %
$ 376 M
Market Cap
-3.75
P/E
TERN - COST OF REVENUE
Cost of Revenue TERN - Terns Pharmaceuticals, Inc.
881 K
LAST VALUE
31.18%
2 YEAR CAGR
68.43%
5 YEAR CAGR
0.00%
10 YEAR CAGR